Britain releases monkey acne response strategies and suggests to provide smallpox vaccines to high -risk people

Xinhua News Agency, London, June 21 (Reporter Guo Shuang) The British Health and Safety Agency issued a strategy of acne response on the 21st. It is recommended to provide ceiling vaccines to people with high -risk people infected with monkey acne infection to control monkey acne transmission. At present, there are nearly 800 cumulative cumulative cases of monkey acne.

The British Health Safety Agency pointed out that although anyone may infect monkey acne, the latest data shows that the risk of spreading monkey acne is more risk of spreading among people such as homosexuality, bisexuality, and other male actors. Monkey acne virus has not yet been defined as sexually transmitted infection, but it can spread through intimate contact in sexual behavior.

Based on the current available vaccine supply and the suggestions of the British vaccination and immunization committee, the British Health and Safety Administration recommends providing smallpox vaccines to high -risk people to block monkey acne transmission.

The British Health and Security Agency said that the British and other European countries have not obtained a vaccine for permissions for the immunity for monkey acne. However, because monkey acne and smallpox belong to acne virus, vaccines for smallpox development are considered to provide cross -protection for monkey acne.

Since the 8th, Britain has listed monkey acne as a legal infectious disease that should be reported. According to data released by the British Health and Security Agency on the 21st, as of the 20th, the British reported 793 laboratory diagnosis cases.

Monkey acne is a kind of viral human and animal disease, which is caused by monkey acne virus infection. Monkey acne virus can be transmitted to people by close contact with animals, and can also be closely contacted by materials contaminated by virus (such as bedding). The initial symptoms of human infection of monkey acne include fever, headache, muscle soreness, back pain, lymph nodes, etc., and can be developed into a large range of rash on the face and body. Most patients will recover within a few weeks, but there are also patients with severe condition and may cause death. Children, pregnant women, and low immune functional people have higher risk of infection.

- END -